However, miR-184, which is known as a putative tumor suppressor and regulates the AKT/mTORC1 pathway by targeting AKT2, TSC2, and PRAS40, is found to be hypermethylated in HBC but not in CMT (Park et al. 2017). This evidence concerns the gene AKT1 and neoplasm.